Publications 2025

Johannessen Landmark C, Sætre J, Gottås A, Wolden M, McQuade TA, Kjeldsen SF, Våtevik A, Sætre E, Svendsen T, Burns ML, Øiestad EL, Johannessen SI (2025)
Pharmacokinetic variability and use of therapeutic drug monitoring of cannabidiol in patients with refractory epilepsy
Epilepsia (in press)
DOI 10.1111/epi.18284, PubMed 39985501

Publications 2024

Heuser K, Romundstad L, Ivanovic J, Egge A, Sætre E, Alfstad K, Sveberg L, Ulvin LB, Taubøll E (2024)
A case of acute functional hemispherotomy in a young woman with hemimegalencephaly and super-refractory status epilepticus
Epilepsy Behav Rep, 28, 100728
DOI 10.1016/j.ebr.2024.100728, PubMed 39651454

Nakken KO, Sætre E, Hlauschek G, Farmen AH, Lossius MI (2024)
Post-stroke epilepsy
Tidsskr Nor Laegeforen, 144 (9)
DOI 10.4045/tidsskr.24.0103, PubMed 39167001

Publications 2020

Heger K, Lund C, Larsen Burns M, Bjørnvold M, Sætre E, Johannessen SI, Johannessen Landmark C (2020)
A retrospective review of changes and challenges in the use of antiseizure medicines in Dravet syndrome in Norway
Epilepsia Open, 5 (3), 432-441
DOI 10.1002/epi4.12413, PubMed 32913951

Johannessen Landmark C, Heger K, Lund C, Burns ML, Bjørnvold M, Sætre E, Johannessen SI (2020)
Pharmacokinetic Variability During Long-Term Therapeutic Drug Monitoring of Valproate, Clobazam, and Levetiracetam in Patients With Dravet Syndrome
Ther Drug Monit, 42 (5), 744-753
DOI 10.1097/FTD.0000000000000781, PubMed 32558674

Nakken KO, Saetre E (2020)
Seizure prevention drugs, not antiepileptic medicinal products
Tidsskr. Nor. Laegeforen., 140 (12), 1278

Nakken KO, Sætre E (2020)
[KO. Nakken and E. Sætre respond]
Tidsskr Nor Laegeforen, 140 (14)
DOI 10.4045/tidsskr.20.0747, PubMed 33070597

Publications 2018

Saetre E, Abdelnoor M (2018)
Incidence rate of sudden death in epilepsy: A systematic review and meta-analysis
Epilepsy Behav, 86, 193-199
DOI 10.1016/j.yebeh.2018.06.037, PubMed 30017838

Publications 2017

Baftiu A, Feet SA, Larsson PG, Burns ML, Henning O, Sætre E, Molden E, Granas AG, Johannessen SI, Landmark CJ (2017)
Utilisation and polypharmacy aspects of antiepileptic drugs in elderly versus younger patients with epilepsy: A pharmacoepidemiological study of CNS-active drugs in Norway, 2004-2015
Epilepsy Res, 139, 35-42
DOI 10.1016/j.eplepsyres.2017.11.001, PubMed 29175562

Publications 2016

Svendsen T, Brodtkorb E, Reimers A, Molden E, Sætre E, Johannessen SI, Johannessen Landmark C (2016)
Pharmacokinetic variability, efficacy and tolerability of eslicarbazepine acetate-A national approach to the evaluation of therapeutic drug monitoring data and clinical outcome
Epilepsy Res, 129, 125-131
DOI 10.1016/j.eplepsyres.2016.12.001, PubMed 28043062

Publications 2013

Nakken KO, Sætre E, Markhus R, Lossius MI (2013)
[Epilepsy in the elderly]
Tidsskr Nor Laegeforen, 133 (5), 528-31
DOI 10.4045/tidsskr.12.0781, PubMed 23463065

Publications 2010

Saetre E, Abdelnoor M, Perucca E, Taubøll E, Isojärvi J, Gjerstad L (2010)
Antiepileptic drugs and quality of life in the elderly: results from a randomized double-blind trial of carbamazepine and lamotrigine in patients with onset of epilepsy in old age
Epilepsy Behav, 17 (3), 395-401
DOI 10.1016/j.yebeh.2009.12.026, PubMed 20149756

Publications 2009

Saetre E, Abdelnoor M, Amlie JP, Tossebro M, Perucca E, Taubøll E, Anfinsen OG, Isojärvi J, Gjerstad L (2009)
Cardiac function and antiepileptic drug treatment in the elderly: a comparison between lamotrigine and sustained-release carbamazepine
Epilepsia, 50 (8), 1841-9
DOI 10.1111/j.1528-1167.2009.02069.x, PubMed 19400874

Publications 2007

Saetre E, Perucca E, Isojärvi J, Gjerstad L, LAM 40089 Study Group (2007)
An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly
Epilepsia, 48 (7), 1292-302
DOI 10.1111/j.1528-1167.2007.01128.x, PubMed 17561956